Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.00
Bid: 0.95
Ask: 1.05
Change: 0.00 (0.00%)
Spread: 0.10 (10.526%)
Open: 1.00
High: 1.00
Low: 1.00
Prev. Close: 1.00
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing, Issue of Equity and TVR

14 Feb 2022 07:00

RNS Number : 5108B
Microsaic Systems plc
14 February 2022
 

14 February 2022

 

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Director Dealing, Issue of Equity and Total Voting Rights

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, announces that it will issue 85,000,000 ordinary shares in the Company (the "Fee Shares") to certain of the Company's directors in respect of their annual remuneration for their second year of service, paid in advance, as outlined in the Company's announcement of 19 January 2021.

 

In addition, the Company received notice from Dr Nigel Burton, Non-Executive Director of the Company of his intention to exercise warrants ("Warrants") relating to 200,000,000 ordinary shares, reflecting an investment of £200,000 in the Company. The Warrants were granted in conjunction with the fundraise completed by the Company in February 2021 (the "Fundraise") at an exercise price of 0.1p, being the Fundraise issue price.

 

Gerry Brandon, Non-executive Chairman of Microsaic Systems, commented:

"The exercise of warrants and investment of £200,000 by Dr. Nigel Burton, Non-executive Director, and our receipt of share based remuneration in lieu of our respective salaries for the second year, represent a strong signal of our full support for Microsaic and the commercial potential to come from its under-exploited technology. It also reflects our continuing belief in the quality of the Microsaic team, whose capabilities and expertise continue to impress."

 

Application has been made to the London Stock Exchange for 285,000,000 ordinary shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 am. on or around 17 February 2022.

 

Director

Position

Annual Remuneration

Number of Fee Shares to be issued

Number of Ordinary Shares issued pursuant to Warrants exercised

Number of Ordinary Shares held on Admission

% of issued share capital held on Admission

Gerard Brandon

Non-Executive Chairman

£50,000

50,000,000

-

190,000,000

2.99

Nigel Burton

Non-Executive Director

£35,000

35,000,000

200,000,000

300,500,000

4.72

 

Total voting rights

 

Following Admission, the Company will have 6,361,365,146 ordinary shares in issue. The Company does not hold any shares in treasury. Therefore, from Admission, the total voting rights in the Company will be 6,361,365,146.

 

From Admission, the figure of 6,361,365,146 may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company pursuant to the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO

 

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

About Microsaic

 

Microsaic develops and commercialises globally micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need: whether within a human health environment; conventional laboratory setting; within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow; or in front-line environmental monitoring.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

Details of the person discharging managerial responsibilities / person closely associated

a) 

Name

Gerard Brandon

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares in lieu of annual remuneration (Fee Shares)

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

50,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Dr Nigel Burton

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares in lieu of annual remuneration (Fee Shares)

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

35,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Dr Nigel Burton

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares pursuant to exercise of warrants

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

200,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUACPUPPPGW
Date   Source Headline
2nd May 20247:00 amRNSCompany Update
27th Mar 20248:49 amRNSCompany Update
16th Feb 20247:00 amRNSCompany Update
25th Jan 20247:00 amRNSCompletion of Acquisition
23rd Jan 20241:30 pmRNSHolding(s) in Company
18th Jan 20246:15 pmRNSHolding(s) in Company
18th Jan 20243:15 pmRNSHolding(s) in Company
18th Jan 202412:00 pmRNSHolding(s) in Company
18th Jan 202410:05 amRNSHolding(s) in Company
16th Jan 20247:30 amRNSRestoration - Microsaic Systems PLC
16th Jan 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSFinal Results
16th Jan 20247:00 amRNSRestoration & Update
15th Jan 20243:45 pmRNSConditional Placing
12th Jan 20244:15 pmRNSAcquisition, Update & Change of Registered Office
4th Jan 20247:00 amRNSUpdate
29th Dec 202311:41 amRNSResult of General Meeting
22nd Dec 20231:27 pmRNSAcquisition & Fundraise Update, Revised Timetable
20th Dec 20233:03 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
20th Dec 202312:30 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
14th Dec 20237:00 amRNSUpdate on Financing, GM & Prospective Acquisition
4th Dec 20237:00 amRNSPublication of Circular and Notice of GM
13th Nov 20238:42 amRNSFunding Update
6th Nov 20237:00 amRNSFunding & Operational Update, Intention to Delist
3rd Nov 20231:32 pmRNSFunding & Operational Update, Intention to Delist
25th Sep 20237:00 amRNSUpdate and Directorate change
3rd Jul 20237:30 amRNSSuspension - Microsaic Systems PLC
29th Jun 20234:00 pmRNSAnnual Financial Report
26th Jun 20237:15 amRNSDeepVerge: debtor update
15th May 20237:15 amRNSAudit update
18th Apr 20237:59 amRNSDeepVerge plc debtor
13th Mar 202310:10 amRNSHolding(s) in Company
28th Dec 20229:25 amRNSHolding(s) in Company
24th Nov 20222:05 pmRNSSecond Price Monitoring Extn
24th Nov 20222:00 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:25 amRNSSupply of mass spectroscopy services to DeepVerge
22nd Aug 20227:00 amRNSPartnership with Kingfield Electronics
5th Jul 20224:41 pmRNSSecond Price Monitoring Extn
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20222:06 pmRNSSecond Price Monitoring Extn
5th Jul 20222:01 pmRNSPrice Monitoring Extension
4th Jul 20224:43 pmRNSReplacement: Trading Update
1st Jul 20222:09 pmRNSHolding(s) in Company
30th Jun 202212:11 pmRNSResult of AGM
30th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSPosting of Annual Report & Notice of AGM
30th May 20227:00 amRNSFinal Results
19th Apr 20227:00 amRNSManufacturing Services Framework Agreement
28th Mar 20227:30 amRNSUpdate on Microsaic's miniaturised technology

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.